Malaria remains a global public health problem. Traditional vaccine development efforts spanning many decades have not been successful. Working towards a rationally designed …
KD Hauns, F Ahmed, S Alemayehu - US Patent 11,013,791, 2021 - Google Patents
The disclosure generally provides a WRrNYVAC comprising multiple antigens from different stages of a malaria parasite (Plasmodium) life cycle, methods for producing them …
CA Cooper, M Mohamadzadeh, JM Moore - 2019 - researchgate.net
Catherine D. Morffy Smith a, Minghao Gong b, Alicer K. Andrew a, Brittany N. Russ b, Yong Ge b, Mojgan Zadeh b, Caitlin A. Cooper a, Mansour Mohamadzadeh b, Julie M. Moore a,⁎ …
Dendritic cells and macrophages are highly heterogenous members of the mononuclear phagocyte system, that share a common lineage precursor in their differentiation …
A highly efficacious vaccine against the malaria parasite Plasmodium falciparum is needed. Repeat sequences are common in P. falciparum proteins and some are known immune …
The enzymes M1 and M17 are used by the malarial parasite Plasmodium falciparum to digest the contents of the human red blood cells during infection. Here, work to characterise …
Malaria is a parasitic disease which puts almost half of the world's population at risk of infection. It is caused by Plasmodium, a parasite transmitted by Anopheles mosquitoes …
A malária é causada por protozoários do gênero Plasmodium. Estima-se que ocorram 212 milhões de casos e 300 mil mortes decorrentes de malária anualmente, principalmente …